Bosua Phillip 4
4 · KNOW LABS, INC. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
KNOW LABS, INC.KNWN
Bosua Phillip
DirectorCEO and President10% Owner
Transactions
- Award
Option to Purchase Common Stock
2022-12-14+1,250,000→ 1,250,000 totalExercise: $1.41Exp: 2027-12-14→ Common Stock (1,250,000 underlying)
Holdings
- 1,000,000
Option to Purchase Common Stock
Exercise: $1.28Exp: 2023-08-01→ Common Stock (1,000,000 underlying) - 4,264,395
Option to Purchase Common Stock
Exercise: $1.53Exp: 2025-12-15→ Common Stock (4,264,395 underlying) - 1,300,000
Option to Purchase Common Stock
Exercise: $2.09Exp: 2026-12-15→ Common Stock (1,300,000 underlying) - 3,005,000
Common Stock
- 1,200,000
Option to Purchase Common Stock
Exercise: $1.10Exp: 2024-11-04→ Common Stock (1,200,000 underlying)
Footnotes (4)
- [F1]Option shares vest 25% quarterly over four years beginning 08/01/2018.
- [F2]Option shares vest upon approval of the Company's blood glucose measurement technology by the U.S. Food and Drug Administration.
- [F3]Milestone-based Option shares vest upon the Company's successful milestone achievements set forth in two Stock Option Agreements dated 12/15/2020.
- [F4]Options vest quarterly over four years. Immediate vesting upon the occurrence of a Change-in-Control.